US 7410644
Recombinant pox virus for immunization against tumor-associated antigens
granted A61KA61K38/00A61P
Quick answer
US patent 7410644 (Recombinant pox virus for immunization against tumor-associated antigens) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Aug 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K38/00, A61P, A61P13/08, A61P35/00